作者信息
- 1. 沈阳二四五医院呼吸科，辽宁 沈阳 110043
- 折叠
摘要
目的：探讨莫西沙星治疗肺炎支原体感染的临床效果。方法对我院2010年12月至2012年12月在我院接受肺炎支原体治疗的76例患者进行回顾性分析，对比莫西沙与阿奇霉素的治疗效果。结果观察组患者治疗的有效率、细菌清除率明显优于对照组，两组患者对比有统计学意义（ P＜0．05）。结论莫西沙星是一种可以有效、安全治疗肺炎支原体感染的药物，值得临床推广。
Abstract
Objective To explore the moxifloxacin clinical effect for the treatment of mycoplasma pneumoniae infection .Methods In our hospital between December 2010 and December 2012 in our hospital of mycoplasma pneumoniae treated 76 cases of patients were analyzed retrospectively,compared to the length and the therapeutic effect of azithromycin.Results Observation group of patients treatment of efficient and bacterial clearance rate was better than control group ,compared two groups of pa-tients was statistically significant(P<0.05).Conclusion Moxifloxacin can is a kind of effective and safe drug treatment of mycoplasma pneumoniae infection ,worth clin-ical promotion.
关键词
阿奇霉素/小儿肺炎/疗效Key words
Azithromycin/Pediatric pneumonia/The curative effect引用本文复制引用
出版年
2014
NETL
NSTL
万方数据